🧬 SYNTHETIC BIOLOGY EDITION - BSL-2+ CERTIFIED 🧬

DsecOS Enterprise

Secure Synthetic Biology Design & Manufacturing Pipeline
Engineer Life. Securely.
Encrypted Audited Accelerated Dual-Use
2

Platform Overview

The world's first fully secure, end-to-end synthetic biology platform, enabling DNA design, gene synthesis ordering, CRISPR simulation, and biomanufacturing orchestration — all within a zero-trust, IP-hardened environment compliant with biosecurity regulations.

Constructs Designed
10,000+/day

AI optimization

CRISPR Simulation
<2 min

Per genome

Cycle Reduction
85%

Design-to-synthesis

Off-Target Risk
-94%

Via AI simulation

Business Value

  • Shorten Design-to-Synthesis Cycle by 85%: Accelerated pipeline
  • Reduce Off-Target Risk by 94%: Via AI simulation
  • Protect £500M+ in IP: With kernel-level encryption
  • Comply with UK HSE, US NIH, and EU Dual-Use Regulations: Out-of-box
âš¡ Trusted By: Biotech unicorns, pharmaceutical giants, and government bio-labs
3

Technical Foundation

Component Role Security & Biofidelity
SynBio CAD (Benchling API) DNA design & version control JWT + client certs
AlphaFold 3 + ESM-2 Protein folding & function prediction Encrypted weights
CRISPR AI Simulator Off-target + efficiency modeling GPU-parallel
Synthesis Gateway Secure order to Twist/Ginkgo HSM-signed manifests
BioManufacturing OS Robot arm + fermenter control ROS 2 + DDS-Security

Platform Security

  • Kernel: BIOS-locked + SELinux synbio_t mandatory access
  • GPU Acceleration: NVIDIA A100 cluster for AlphaFold + diffusion models
  • DNA Encryption: Post-quantum watermarking (Kyber + lattice codes)
  • Audit DNA Chain: Immutable, blockchain-anchored synthesis logs
4

Bio-Secure Cluster Architecture

9-Node Bio-Secure Lab (BSL-2+ Capable)

graph TD subgraph "DsecOS Bio-Secure Cluster (9 Nodes)" N1[DsecOS Node 1
Design Portal + HSM] N2[DsecOS Node 2
AlphaFold GPU] N3[DsecOS Node 3
CRISPR Simulator GPU] N4[DsecOS Node 4
Synthesis Gateway] N5[DsecOS Node 5
Manufacturing OS] N6[DsecOS Node 6
Ceph WORM + DNA Vault] N7[DsecOS Node 7
AI Optimizer] N8[DsecOS Node 8
Audit Chain] N9[DsecOS Node 9
Biosafety Monitor] end subgraph "Synthetic Biology Pipeline" CAD["SynBio CAD
(Benchling)"] AF["AlphaFold 3
(Structure)"] CRISPR["CRISPR AI
(Off-Target)"] SYNTH["DNA Synthesis
(Twist/Ginkgo)"] MANUF["BioManufacturing
(Robots + Fermenters)"] end subgraph "Security & Compliance" HSM["HSM Key Vault
(DNA Watermark)"] AI["Design Optimizer
(Diffusion Model)"] AUDIT["DNA Audit Chain
(WORM + Anchor)"] LIC[License Server
Bio Edition] end N1 <-->|Corosync HA
Encrypted| N2 N2 <--> N3 N3 <--> N4 N4 <--> N5 N5 <--> N6 N6 <--> N7 N7 <--> N8 N8 <--> N9 N1 --> CEPH[Ceph DNA Vault
WORM + Quantum-Resistant] CAD --> N1 AF --> N2 CRISPR --> N3 SYNTH --> N4 MANUF --> N5 HSM --> N1 AI --> N7 AUDIT --> N8 style N1 fill:#121212,stroke:#00D9A5,color:#FFF style CRISPR fill:#1E1E1E,stroke:#00D9A5,color:#FFF style HSM fill:#8B0000,color:#FFF
5

Design-to-Manufacture Flow

journey title Synthetic Biology Design-to-Manufacture Flow section Design Upload Target Protein: 5: CAD Portal AI Optimize Sequence: 5: ESM-2 + Diffusion Watermark DNA (Kyber): 5: HSM section Simulate Predict Fold (AlphaFold): 5: 1.8 min CRISPR Off-Target Scan: 5: 94% Risk Reduction Auto-Approve Construct: 4: AI Gate section Synthesize HSM-Sign Order: 5: Secure API Send to Foundry: 5: Encrypted Manifest Track Shipment: 4: Blockchain section Manufacture & Audit Robot Load DNA: 5: ROS 2 Ferment 48h: 5: Real-Time Archive Full Chain: 5: WORM + NIH Report
6

Deployment Requirements

âš¡ Prerequisites: DsecOS Enterprise Bio Edition license (dual-use approved), 9x bio-secure servers (256 GB RAM, 4x A100 GPU, 64 TB NVMe), Benchling, Twist Bioscience, Ginkgo Bioworks integration

Step 1: Provision Bio-Secure Cluster

/scripts/pxe-deploy.sh --cluster synbio-lab --nodes 9 --bio-mode --hsm-dna --gpu a100

Step 2: Deploy SynBio Stack

Create /templates/stacks/synbio-pipeline.yml:

version: '3.8'
services:
  cad-portal:
    image: dsecos/synbio-cad:latest
    ports:
      - "9443:9443"
    environment:
      - BENCHLING_API_KEY=***
      - HSM_URL=/dev/hsm0

  alphafold:
    image: dsecos/alphafold3:latest
    deploy:
      resources:
        reservations:
          devices:
            - driver: nvidia
              count: 4
              capabilities: [gpu]
    command: --model multimer --fasta input.fasta

  crispr-ai:
    image: dsecos/crispr-sim:latest
    command: scan --genome hg38 --guide seq --mismatches 3

  synthesis-gateway:
    image: dsecos/dna-order:latest
    environment:
      - TWIST_API_KEY=***
    command: --encrypt kyber --sign hsm

  manuf-os:
    image: dsecos/bio-ros2:latest
    privileged: true
    command: launch fermenter_control.launch

  audit-chain:
    image: dsecos/dna-audit:latest
    volumes:
      - ceph-worm:/audit
    command: --worm --anchor ipfs --compliance nih

volumes:
  ceph-worm:
    driver: cephfs
    driver_opts:
      worm: true

Deploy Command

dsecos deploy synbio-pipeline
7

Test Full Pipeline

# Design insulin analog
curl -X POST https://node1:9443/api/design \
  -H "Authorization: Bearer $JWT" \
  -d '{"target": "insulin", "optimize": "stability"}'

Results

  • Output: Encrypted, watermarked DNA order in <3 minutes
  • Compliance: Auto-generates US NIH biosecurity submission
  • IP Protection: DNA IP lock with watermark + quantum-resistant encryption
8

Security & Biosafety

DNA IP Lock
100%

Watermark + encryption

Biosafety AI
Auto

Flags dual-use sequences

Compliance
NIH

US, UK HSE, EU

IP Breach Attempts
100%

Blocked

Compliance Standards

  • US NIH: National Institutes of Health biosecurity
  • UK HSE: Health and Safety Executive regulations
  • EU Dual-Use Annex I: European Union export controls
  • Biosafety AI: Auto-flags dual-use sequences
9

Performance & Biofidelity Metrics

Metric Value
Constructs Designed/Day 12,400
Off-Target Risk Reduction 94.2%
Synthesis Turnaround 48 hours
IP Breach Attempts Blocked 100%
12.4K
Daily
94.2%
Risk Reduction
48h
Synthesis
100%
IP Protected
10

Return on Investment

Synthetic Insulin Manufacturer Example

Category Current Costs With DsecOS Net Savings
Annual Operating Costs £42,000,000 £11,000,000 £31,000,000
IP Value £0 £18,000,000 +£18,000,000
Time to Market Baseline 6 months faster Accelerated
Total Net Savings £42,000,000 -£7,000,000 £49,000,000
Total Annual Net Savings
£49,000,000+
Plus 6 months faster to market

Where Biology Meets Unbreakable Security

12.4K
Daily
94.2%
Risk Reduction
£49M
Savings
100%
IP Protected
"From DNA to Product. Encrypted. Audited. Accelerated."
BSL-2+ DUAL-USE IP-HARDENED NIH COMPLIANT
DsecOS Enterprise Synthetic Biology Edition